The 70–80% of all ALK-positive ALCL patients present the ALK gene (2p23) and the NPM (nucleolar phosphoprotein B23, numatrin) gene (5q35) translocation [13] with several t(2;5) breakpoint variants described. The gene discussed is ALK; the disease is anaplastic large cell lymphoma.